Articoli con mandati relativi all'accesso pubblico - Michael ClarksonUlteriori informazioni
Non disponibile pubblicamente: 1
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
P McCoy, S Mangiola, G Macintyre, R Hutchinson, B Tran, B Pope, ...
Prostate cancer and prostatic diseases 24 (4), 1167-1180, 2021
Mandati: National Health and Medical Research Council, Australia
Disponibili pubblicamente: 5
WT1 maintains adrenal-gonadal primordium identity and marks a population of AGP-like progenitors within the adrenal gland
R Bandiera, VPI Vidal, FJ Motamedi, M Clarkson, I Sahut-Barnola, ...
Developmental cell 27 (1), 5-18, 2013
Mandati: US National Institutes of Health, UK Medical Research Council
COUP-TFI promotes radial migration and proper morphology of callosal projection neurons by repressing Rnd2 expression
C Alfano, L Viola, JIT Heng, M Pirozzi, M Clarkson, G Flore, A De Maio, ...
Development 138 (21), 4685-4697, 2011
Mandati: Fondazione Telethon, Italy
Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
E Lau, P McCoy, F Reeves, K Chow, M Clarkson, EM Kwan, K Packwood, ...
Genome medicine 12, 1-11, 2020
Mandati: US National Institutes of Health
Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation
PJ McCoy, AJ Costello, NM Corcoran, CM Hovens, C Michael J
MethodsX, 22-34, 2018
Mandati: National Health and Medical Research Council, Australia
MSH2 is Inactivated by Multiple Mechanisms in Prostate Tumors, Leading to a Distinct Immune Response and Clinical Outcome Compared to MSH2 Deficient Colorectal Cancer
P McCoy, S Mangiola, G Macintyre, R Hutchinson, B Tran, MKH Hong, ...
Mandati: National Health and Medical Research Council, Australia
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software